Axa
BMEA icon

Axa’s Biomea Fusion BMEA Stock Holding History

Axa’s Portfolio BMEA Stock Details BMEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-117,000
Closed -$522K – 1122
2022
Q1 		$522K Buy
117,000
+2
+0% +$13 ﹤0.01% 1035
2021
Q4 		$872K Buy
116,998
+1,398
+1% +$14.8K ﹤0.01% 968
2021
Q3 		$1.38M Buy
115,600
+4,250
+4% +$54.1K ﹤0.01% 929
2021
Q2 		$1.74M Buy
+111,350
New +$1.97M ﹤0.01% 908

Other funds holding BMEA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Axa's BMEA Position: Q2 2022 in Review

Axa sold out of Biomea Fusion (BMEA) in Q2 2022, closing a stake of 117,000 shares — an estimated $522K sold.

Axa first reported a position in BMEA in Q2 2021 and held it in 4 quarters. The position peaked at $1.74M in Q2 2021. 42 funds tracked by Wall St. Rank hold BMEA as of Q2 2022.

  • Axa reported no remaining Biomea Fusion position as of Q2 2022 after selling out during the quarter.
  • Axa sold 117,000 Biomea Fusion shares in Q2 2022, an estimated $522K.
  • Axa first reported a position in Biomea Fusion in Q2 2021 and held it in 4 quarters.
  • Axa's Biomea Fusion position peaked at $1.74M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.